Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Metabolic Disease

Metabolic Disease

Metabolic diseases encompass various disorders resulting in the physiological and biochemical imbalances, affecting various organs including liver, pancreas and adipose tissue leading to the development of several health complications such as diabetes, diabetic complications, obesity, and NASH. Syngene’s expertise in preclinical animal models for metabolic diseases can provide valuable insights into the efficacy and safety of potential therapeutic interventions. We are specialized in various chemical, genetic and diet induced in vivo pharmacology efficacy models for metabolic diseases.

Categories:

  1. Diabetes and Obesity
  2. Diabetes complications
  3. Germfree mice capabilities
  4. Humanized liver model
  5. NASH

List of validated animal models: Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details